Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Seroprevalence of Herpes Simplex Virus Infection in HIV Coinfected Individuals in Eastern India with Risk Factor Analysis.

Nag S, Sarkar S, Chattopadhyay D, Bhattacharya S, Biswas R, SenGupta M.

Adv Virol. 2015;2015:537939. doi: 10.1155/2015/537939. Epub 2015 Oct 19.

2.

The Current State of Vaccine Development for Ocular HSV-1 Infection.

Royer DJ, Cohen A, Carr D.

Expert Rev Ophthalmol. 2015 Apr 1;10(2):113-126.

3.

A perfect storm: crack cocaine, HSV-2, and HIV among non-injecting drug users in New York City.

Des Jarlais DC, McKnight C, Arasteh K, Feelemyer J, Perlman DC, Hagan H, Dauria EF, Cooper HL.

Subst Use Misuse. 2014 Jun;49(7):783-92. doi: 10.3109/10826084.2014.880176. Epub 2014 Feb 6.

4.

Safety, formulation, and in vitro antiviral activity of the antimicrobial peptide subtilosin against herpes simplex virus type 1.

Torres NI, Noll KS, Xu S, Li J, Huang Q, Sinko PJ, Wachsman MB, Chikindas ML.

Probiotics Antimicrob Proteins. 2013 Mar 1;5(1):26-35. doi: 10.1007/s12602-012-9123-x. Erratum in: Probiotics Antimicrob Proteins. 2013 Mar;5(1):36.

5.
6.

Performance of the Euroline Western blot assay in the detection of herpes simplex virus type 2 antibody in Uganda, China and the USA.

Neal JD, Tobian AA, Laeyendecker O, Ngo TD, Redd AD, Reynolds SJ, Ashley Morrow R, Manucci JL, Serwadda D, Gray RH, Quinn TC.

Int J STD AIDS. 2011 Jun;22(6):342-4. doi: 10.1258/ijsa.2009.009327.

7.

Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition.

Zhu J, Hladik F, Woodward A, Klock A, Peng T, Johnston C, Remington M, Magaret A, Koelle DM, Wald A, Corey L.

Nat Med. 2009 Aug;15(8):886-92. doi: 10.1038/nm.2006. Epub 2009 Aug 2.

8.

Explaining racial disparities in HIV/AIDS incidence among women in the U.S.: a systematic review.

Tillerson K.

Stat Med. 2008 Sep 10;27(20):4132-43. doi: 10.1002/sim.3224.

9.

Herpes simplex virus type 2 seroprevalence in Korea: rapid increase of HSV-2 seroprevalence in the 30s in the southern part.

Shin HS, Park JJ, Chu C, Song HJ, Cho KS, Lee JS, Kim SS, Kee MK.

J Korean Med Sci. 2007 Dec;22(6):957-62.

10.
11.

High seroprevalence of herpes simplex virus type 2 infection in French human immunodeficiency virus type 1-infected outpatients.

Andréoletti L, Piednoir E, Legoff J, Brodard V, Beguinot I, Strady C, Rouger C, Piketty C, Si-Mohamed A, Kazatchkine MD, Malkin JE, Bélec L.

J Clin Microbiol. 2005 Aug;43(8):4215-7.

14.

Hepatitis C virus infection in young, low-income women: the role of sexually transmitted infection as a potential cofactor for HCV infection.

Page-Shafer KA, Cahoon-Young B, Klausner JD, Morrow S, Molitor F, Ruiz J, McFarland W; Young Women's Survey Team.

Am J Public Health. 2002 Apr;92(4):670-6.

15.

Construction, phenotypic analysis, and immunogenicity of a UL5/UL29 double deletion mutant of herpes simplex virus 2.

Da Costa X, Kramer MF, Zhu J, Brockman MA, Knipe DM.

J Virol. 2000 Sep;74(17):7963-71.

16.

Prevalence of HIV infection, sexually transmitted diseases, and hepatitis and related risk behavior in young women living in low-income neighborhoods of northern California.

Ruiz JD, Molitor F, McFarland W, Klausner J, Lemp G, Page-Shafer K, Parikh-Patel A, Morrow S, Sun RK.

West J Med. 2000 Jun;172(6):368-73.

17.

Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population.

Kamali A, Nunn AJ, Mulder DW, Van Dyck E, Dobbins JG, Whitworth JA.

Sex Transm Infect. 1999 Apr;75(2):98-102.

18.

Genital herpes: review of the epidemic and potential use of type-specific serology.

Ashley RL, Wald A.

Clin Microbiol Rev. 1999 Jan;12(1):1-8. Review.

19.

Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract.

Howell AL, Edkins RD, Rier SE, Yeaman GR, Stern JE, Fanger MW, Wira CR.

J Virol. 1997 May;71(5):3498-506.

20.

Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.

Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J.

J Clin Invest. 1997 Mar 1;99(5):1092-7.

Supplemental Content

Support Center